Finzati - Logo
EW logo

Edwards Lifesciences Corporation

EW • Medical - Devices
$89.90
▲ +0.12 (+0.13%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$51.93B
Growth
8.3%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 17.7%Positive revenue growth · 5.4%Positive free cash flow · 2.28Consistent free cash flow · 5/5Manageable debt level · 0.07
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:15 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$89.90
Change0.13%
Shares Out577.60M
Market Cap$51.93B
Enterprise Value$48.27B
52W Range72.30 - 96.29
Beta0.86
P/E51.67
P/S7.97
P/B4.89
P/FCF34.61
EV/Sales7.41

Investment DNA

How strong this company looks for long-term investors

68
out of 100
Business Quality
Margins, moat, returns
76/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
55/100
Price Attractiveness
Cheap or expensive today
35/100
Why this score▼
Stable or improving margins · 17.7%Positive revenue growth · 5.4%Positive free cash flow · 2.28Consistent free cash flow · 5/5Manageable debt level · 0.07Healthy liquidity · 3.72

Analyst view

Analyst sentiment and price target

EW
Analyst sentiment
Based on 49 analyst votes · 2026-09-05
84/100
Bullish
Bullish
33
Hold
16
Bearish
0
Price Target
2026-08-06
Low
$85.00
Mean
$101.09
Median
$101.00
High
$110.00

Company Overview

IPO: 3/27/2000
Industry: Medical - Devices
P/B i: 4.89
Debt / Equity i: 0.07
Operating Margin: 26.97%
Net Margin: 17.69%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.07
Current Ratio: 3.72
Quick Ratio: 3.09
Status: Good

Insider Transactions

Recent executive and insider activity

Markowitz Wayne
Transaction: 07/30/2026
SELL
Change
—
Price
$86.03
Filing
07/30/2026
Type
SELL
Markowitz Wayne
Transaction: 07/28/2026
SELL
Change
-9,628
Price
$74.02
Filing
07/28/2026
Type
SELL
Markowitz Wayne
Transaction: 07/28/2026
SELL
Change
-9,628
Price
$85.06
Filing
07/28/2026
Type
SELL